Market Data
News
Tools
Markets
Discover
Subscribe Login/Register
FTSE 100
7,446.14
(
-1.01%
)
Dow Jones
32,908.27
(
-0.41%
)
Gold vs US Dollar
1,967.025
(
0.03%
)
Brent Oil
72.335
(
0.31%
)
Bitcoin
27,141.93
(
-0.29%
)
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Unicorn Aim Vct Plc (UAV)

  7. Unicorn Aim Vct Plc (UAV) Share Price

UAV

Unicorn Aim Vct Plc

108.50
3.00 (2.84%)
Upgrade to Real-Time
Share Name Share Symbol Market Type Share ISIN Share Description
Unicorn Aim Vct Plc LSE:UAV London Ordinary Share GB00B1RTFN43 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
Upgrade Icon
  3.00 2.84% 108.50 2,000 09:00:20
Bid Price Offer Price High Price Low Price Open Price
105.00 112.00 108.50 105.50 105.50
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Investors, Nec -99.12 -105.18 -64.10 - 188.90
Last Trade Time Trade Type Trade Size Trade Price Currency
08:50:26 O 2,000 109.00 GBX
Related Shares
Scottish Mortgage Invest... (SMT), M&g (MNG), Tiger Royalties And Inve... (TIR), Golden Rock Global (GCG)

Unicorn Aim Vct (UAV) Latest News (5)

Unicorn Aim Vct News

Date Time Source Headline
31/5/202309:52ALNCNewsIN BRIEF: Unicorn AIM VCT net asset value down in first half
31/5/202307:00UKREGUnicorn AIM VCT PLC Half-year Report
05/5/202309:20UKREGUnicorn AIM VCT PLC Net Asset Value(s)
06/4/202310:53UKREGUnicorn AIM VCT PLC Net Asset Value(s)
03/4/202310:25UKREGUnicorn AIM VCT PLC Total Voting Rights
10/3/202316:32UKREGUnicorn AIM VCT PLC Transaction in Own Shares
03/3/202317:36UKREGUnicorn AIM VCT PLC Net Asset Value(s)
01/3/202309:52UKREGUnicorn AIM VCT PLC Total Voting Rights
22/2/202316:04UKREGUnicorn AIM VCT PLC Director/PDMR Shareholding
22/2/202309:14UKREGUnicorn AIM VCT PLC Issue of Equity

Unicorn Aim Vct (UAV) Discussions and Chat

Unicorn Aim Vct Forums and Chat

Date Time Title Posts
12/8/202207:49Unicorn AIM VCT16

Add a New Thread

Unicorn Aim Vct (UAV) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2023-05-31 07:50:27109.002,0002,180.00O

Unicorn Aim Vct (UAV) Top Chat Posts

Top Posts
Posted at 18/7/2022 09:16 by gbcol
It’s 3p & 32p.

“Following the sale of Interactive the Board has decided to distribute the entire realised gain by way of a Special Dividend of 32.0 pence per share alongside the interim dividend of 3.0 pence per share. This interim dividend and the special interim dividend will be paid on 11 August 2022 to Shareholders on the register on 15 July 2022. The shares will be quoted ex-dividend on 14 July 2022.”
Read Full Thread
Follow
Reply
Posted at 17/3/2022 14:12 by toffeeman
Just bought some of the new issue and with VCT relief my entry price is 138. Now need to leave it alone for 5 years :)
Read Full Thread
Follow
Reply
Posted at 08/12/2021 17:11 by sphere25
This is topical:

" Largest Detractors

Avacta Group (-GBP1.6 million) is a clinical stage biopharmaceutical specialist and a developer of diagnostics tools based on innovative and proprietary Affimer(R) and pre|CISION(TM) platforms. At the end of September, Avacta released interim results, which confirmed that the business continues to struggle to achieve widespread commercial adoption of its high quality Lateral Flow Tests. Financial results were therefore below original expectations and Avacta's share price has been under considerable pressure as a result.

Omega Diagnostics (-GBP1.2 million) is a business focused on providing specialist products to immunoassay, in-vitro diagnostics (IVD) market within the Health & Wellbeing sector. During the year, Omega released results for its financial year ended 31 March 2021. Because of the severe disruption caused by the pandemic, revenues did not grow as quickly as originally anticipated and the share price has suffered accordingly.

Abingdon Health (-GBP1.1 million) is a developer and manufacturer of high-quality rapid lateral flow tests. Unfortunately, throughout the year under review, Abingdon has been embroiled in a commercial dispute with the Department of Health and Social Care (DHSC), which translated into significantly lower than expected demand for its AbC-19 rapid antibody testing product. In addition, the DHSC continues to withhold payments due to Abingdon that amount to GBP6.7 million. This dispute remains unresolved, despite Abingdon's insistence that the contract was delivered to the DHSC on time, on budget and in full. As a result, Abingdon has failed to meet growth expectations in the twelve months since its initial listing on the FTSE AIM All-Share Index.

Genedrive (-GBP0.9 million) is a molecular diagnostics company that develops and commercialises low cost, rapid, versatile, and simple to use testing platforms for the diagnosis of infectious diseases. In its half yearly report, covering the six months to 31 December 2020, Genedrive was only able to generate nominal revenues as Covid-19 headwinds continued to impact its commercial operations. In September 2021, Genedrive raised GBP6 million in additional capital in order to fund the launch of a point-of-care (POC) antibiotic induced hearing loss (AIHL) test and complete the development of its molecular Covid-19 test. "

Should be interesting to see how they all fare next year!
Read Full Thread
Follow
Reply
Unicorn Aim Vct share price data is direct from the London Stock Exchange
Your Recent History
LSE
UAV
Unicorn Ai..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com

V: D: 20230601 01:21:28